Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mahoney

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Pediatric Blood & Cancer|July 16, 2008
A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare qualityJean L Raphael, Priya B Shetty, Hao Liu, et al.
Pediatric Blood & Cancer|April 3, 2008
Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospitalJean L Raphael, Aditi Kamdar, M Brooke Beavers, et al.
Pediatric Blood & Cancer|August 4, 2005
Prolonged QT interval in pediatric sickle cell diseaseBrigitta U Mueller, Kahlil J Martin, William Dreyer, et al.
Cancer|November 15, 1990
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group studyC K Tebbi, J Krischer, D J Fernbach, et al.
The Journal of Pediatrics|July 8, 2015
Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute ThrombosisRosa Diaz, Brady S Moffett, Shaina Karabinas, et al.
The Journal of Pediatrics|January 1, 1992
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remissionM M Chintagumpala, R L Hurwitz, J L Moake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
American Journal of Hematology|March 18, 2021
Phosphorus levels in children treated with intravenous ferric carboxymaltoseSusan E Kirk, Michael E Scheurer, Melanie Brooke Bernhardt, et al.
The Pediatric Infectious Disease Journal|September 15, 2012
Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complicationsJ Chase McNeil, Kristina G Hulten, Sheldon L Kaplan, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosisD H Mahoney, K L McClain, I C Hanson, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Pediatric Blood & Cancer|July 16, 2008
A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare qualityJean L Raphael, Priya B Shetty, Hao Liu, et al.
Pediatric Blood & Cancer|April 3, 2008
Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospitalJean L Raphael, Aditi Kamdar, M Brooke Beavers, et al.
Pediatric Blood & Cancer|August 4, 2005
Prolonged QT interval in pediatric sickle cell diseaseBrigitta U Mueller, Kahlil J Martin, William Dreyer, et al.
Cancer|November 15, 1990
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group studyC K Tebbi, J Krischer, D J Fernbach, et al.
The Journal of Pediatrics|July 8, 2015
Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute ThrombosisRosa Diaz, Brady S Moffett, Shaina Karabinas, et al.
The Journal of Pediatrics|January 1, 1992
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remissionM M Chintagumpala, R L Hurwitz, J L Moake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
American Journal of Hematology|March 18, 2021
Phosphorus levels in children treated with intravenous ferric carboxymaltoseSusan E Kirk, Michael E Scheurer, Melanie Brooke Bernhardt, et al.
The Pediatric Infectious Disease Journal|September 15, 2012
Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complicationsJ Chase McNeil, Kristina G Hulten, Sheldon L Kaplan, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosisD H Mahoney, K L McClain, I C Hanson, et al.
Pageof 16